Parameters | Healthy control (n = 10) | HCV patients (n = 10) | HCC patients (n = 28) | p-value HCC vs healthy control | p-value HCC vs HCV |
---|---|---|---|---|---|
Gender | |||||
Female n (%) | 1 (10) | 1 (10) | 3 (10.7) | 0.950b | 0.095b |
Male n (%) | 9 (90) | 9 (90) | 25 (89.3) | ||
Age (years) | 60.5 (56.5–62) | 64 (60–69.3) | 60 (58–63.7) | 0.950a | 0.075a |
AST (U/L) | 12.5 (11.75–18.25) | 24.0 (18.7–35.2) | 50.5 (35–107) | < 0.0001a | 0.001a |
ALT (U/L) | 17.0 (12.50–21.25) | 24.0 (12.0–51.7) | 47.5 (27.75–63.60) | 0.0002a | 0.0414a |
INR | 0.85 (0.61–1.10) | 1.04 (1.0–1.29) | 1.20 (1.10–1.39) | < 0.0001a | 0.0158a |
Albumin (g/dl) | 3.90 (3.15–4.60) | 3.90 (3.30–4.65) | 3.35 (2.62–3.60) | 0.0018a | 0.104a |
Total bilirubin (mg/dl) | 0.40 (0.20–0.85) | 0.50 (0.27–0.92) | 1.30 (0.90–2.30) | < 0.0001a | 0.0002a |
BUN (mg/dl) | 17.5 (9.2–20.2) | 20.5 (17.0–24.0) | 20.0 (12.0–32.0) | 0.2801a | 0.8941a |
Creatinine (mg/dl) | 0.90 (0.70–1.03) | 0.95 (0.77–1.12) | 0.95 (0.80–1.20) | 0.4487a | 0.752a |